以葡萄为灵感的聚合物囊具有等级微结构:用于储能,药物输送,催化和环境应用的先进纳米材料载体平台
Youngkyun Jung1, Su-Jin Yoon1, Yun Lee1,2
1Center for Water Cycle Research, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.
Small (Weinheim an der Bergstrasse, Germany)
|May 1, 2024
概括
一种新的葡萄灵感的聚合物囊 (GPC) 为支持纳米材料提供了一种高效的解决方案. 这种载体平台通过防止泄漏和提高稳定性,提高了储能,催化和环境修复方面的性能.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
- 化学工程是化学工程的重要组成部分.
背景情况:
- 传统的纳米材料支面临着诸如高重量比率和管理能力差等局限性,阻碍了应用.
- 诸如管道堵塞和二次污染等问题来自传统支材料.
- 开发先进的载体对于释放纳米材料的全部潜力至关重要.
研究的目的:
- 推出一种新的葡萄灵感的聚合物囊 (GPC) 作为纳米材料的高性能载体.
- 评估GPC封装各种纳米材料的能力及其对其稳定性和性能的影响.
- 在各种应用中展示GPC在传统支材料上的优势.
主要方法:
- 制造具有水友性外和等级微观结构的毫米尺度GPC.
- 使用液相自下向上方法将各种纳米材料 (Fe2O3,SiO2,聚烯酸,普鲁士蓝) 装载到GPC上.
- GPC属性的表征,包括空体积,承载能力和稳定性.
主要成果:
- 在加载的纳米材料中,GPC实现了高质量比 (例如Fe2O3的1776重量%).
- GPC外有效地防止了纳米材料的泄漏,并暂停了固体的流入.
- 内部框架改善了封装纳米材料的结构稳定性和质量转移率.
结论:
- 以葡萄为灵感的聚合物囊 (GPC) 证明了不同纳米材料的特殊承载能力和稳定性.
- GPCs提供了一个多功能和高效的平台,用于增强纳米材料在储能,药物输送,催化和环境修复中的应用.
- 这种新的载体系统克服了传统支器的局限性,为更广泛,更有效地使用纳米材料铺平了道路.
相关概念视频
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
137
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
137
01:19Modified-Release Drug Delivery Systems: Overview
236
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
236
01:23Modified-Release Drug Delivery Systems: Classification
315
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
315
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
177
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
177
01:24Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160